Ziftomenib

Generic Name: Ziftomenib

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₃₃H_₄₂F_₃N_₉O_₂S_₂

CAS Number: 2134675-36-6

Unique Ingredient Identifier: 4MOD1F4ENC

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias

Phase 1

Recruiting

Conditions: Refractory Acute Leukemia
Pediatric Relapsed

Interventions: Drug: Ziftomenib
Drug: Venetoclax
Drug: Azacitidine

First Posted Date: 2024-05-02

Last Posted Date: 2025-01-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 22

Registration Number: NCT06397027

Locations: 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy